Chemomab Therapeutics Ltd Adr stock is traded at $1.27, with a volume of 2,001. It is up +1.60% in the last 24 hours and down -9.29% over the past month. Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Previous Close:
$1.25
Open:
$1.27
24h Volume:
2,001
Relative Volume:
0.03
Market Cap:
$10.22M
Revenue:
-
Net Income/Loss:
-$7.50M
P/E Ratio:
-
EPS:
-$1.11
Net Cash Flow:
-$23.55M
1W Performance:
+9.48%
1M Performance:
-9.29%
6M Performance:
-29.05%
1Y Performance:
-50.78%
1-Day Range:
$1.27$1.28
1-Week Range:
$1.14$1.33
52-Week Range:
$0.9201$2.99
Chemomab Therapeutics Ltd Adr Stock (CMMB) Company Profile
Name
Chemomab Therapeutics Ltd AdrSector
HealthcareIndustry
BiotechnologyPhone
972-77-331-0156Address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS